Fox Run Management, L.L.C. Cara Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$8.88 - $12.77 $122,641 - $176,366	13,811 New	13,811 $148,000
Q2 2022 Aug 12, 2022	SELL	$7.45 - $13.84 $81,488 - $151,381	-10,938 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$9.94 - $12.65 $108,723 - $138,365	10,938 New	10,938 $133,000
Q1 2018 Apr 17, 2018	SELL	$11.77 - $16.08 $150,656 - $205,823	-12,800 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$11.86 - $14.08 $151,808 - $180,224	12,800	12,800 $157,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.